BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32236885)

  • 21. Patient Navigation After Positive Fecal Immunochemical Test Results Increases Diagnostic Colonoscopy and Highlights Multilevel Barriers to Follow-Up.
    Cusumano VT; Myint A; Corona E; Yang L; Bocek J; Lopez AG; Huang MZ; Raja N; Dermenchyan A; Roh L; Han M; Croymans D; May FP
    Dig Dis Sci; 2021 Nov; 66(11):3760-3768. PubMed ID: 33609211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient randomized trial of a targeted navigation program to improve rates of follow-up colonoscopy in community health centers.
    Coronado GD; Johnson ES; Leo MC; Schneider JL; Smith D; Mummadi R; Petrik AF; Thompson JH; Jimenez R
    Contemp Clin Trials; 2020 Feb; 89():105920. PubMed ID: 31881390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barriers associated with inadequate follow-up of abnormal fecal immunochemical test results in a safety-net system: A mixed-methods analysis.
    Issaka RB; Bell-Brown A; Kao J; Snyder C; Atkins DL; Chew LD; Weiner BJ; Strate L; Inadomi JM; Ramsey SD
    Prev Med Rep; 2022 Aug; 28():101831. PubMed ID: 35637893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.
    Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA
    J Gen Intern Med; 2016 Oct; 31(10):1190-7. PubMed ID: 27279097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disparities in Colorectal Cancer Screening Practices in a Midwest Urban Safety-Net Healthcare System.
    Elangovan A; Skeans J; Lalani I; Ullah F; Roy A; Kaelber DC; Cooper GS; Sandhu DS
    Dig Dis Sci; 2021 Aug; 66(8):2585-2594. PubMed ID: 32816217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colonoscopy Following an Abnormal Fecal Test Result from an Annual Colorectal Cancer Screening Program in a Federally Qualified Health Center.
    Escaron AL; Garcia J; Petrik AF; Ruiz E; Nyongesa DB; Thompson JH; Coronado GD
    J Prim Care Community Health; 2022; 13():21501319221138423. PubMed ID: 36448466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving colorectal cancer screening in rural primary care: Preliminary effectiveness and implementation of a collaborative mailed fecal immunochemical test pilot.
    Davis MM; Coury J; Larson JH; Gunn R; Towey EG; Ketelhut A; Patzel M; Ramsey K; Coronado GD
    J Rural Health; 2023 Jan; 39(1):279-290. PubMed ID: 35703582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical utility of a blood-based protein assay to increase screening of elevated-risk patients for colorectal cancer in the primary care setting.
    Peabody J; Paculdo D; Swagel E; Fugaro S; Tran M
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2301-2307. PubMed ID: 28710715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial.
    Coronado GD; Vollmer WM; Petrik A; Taplin SH; Burdick TE; Meenan RT; Green BB
    Contemp Clin Trials; 2014 Jul; 38(2):344-9. PubMed ID: 24937017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follow-up colonoscopy after an abnormal stool-based colorectal cancer screening result: analysis of steps in the colonoscopy completion process.
    Coronado GD; Kihn-Stang A; Slaughter MT; Petrik AF; Thompson JH; Rivelli JS; Jimenez R; Gibbs J; Yadav N; Mummadi RR
    BMC Gastroenterol; 2021 Sep; 21(1):356. PubMed ID: 34583638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guideline Adherence to Colonoscopic Surveillance Intervals after Polypectomy in Korea: Results from a Nationwide Survey.
    Hong S; Suh M; Choi KS; Park B; Cha JM; Kim HS; Jun JK; Han DS
    Gut Liver; 2018 Jul; 12(4):426-432. PubMed ID: 29429156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-reported screening practices of family physicians participating in the colorectal cancer screening program of the canton of Vaud: a cross-sectional study.
    Poroes C; Cornuz J; Gouveia A; Ducros C; Selby K
    BMC Fam Pract; 2020 Jun; 21(1):103. PubMed ID: 32522159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Survey of Provider Attitudes, Beliefs, and Perceived Barriers Regarding a Centralized Direct-Mail Colorectal Cancer Screening Approach at Community Health Centers.
    Thompson JH; Schneider JL; Rivelli JS; Petrik AF; Vollmer WM; Fuoco MJ; Coronado GD
    J Prim Care Community Health; 2019; 10():2150132719890950. PubMed ID: 31779517
    [No Abstract]   [Full Text] [Related]  

  • 34. Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.
    Partin MR; Gravely AA; Burgess JF; Haggstrom DA; Lillie SE; Nelson DB; Nugent SM; Shaukat A; Sultan S; Walter LC; Burgess DJ
    Cancer; 2017 Sep; 123(18):3502-3512. PubMed ID: 28493543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRC Screening Results: Patient Comprehension and Follow-up.
    Azulay R; Valinsky L; Hershkowitz F; Magnezi R
    Cancer Control; 2019; 26(1):1073274819825828. PubMed ID: 30704290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementing Mailed Colorectal Cancer Fecal Screening Tests in Real-World Primary Care Settings: Promising Implementation Practices and Opportunities for Improvement.
    Hohl SD; Maxwell AE; Sharma KP; Sun J; Vu TT; DeGroff A; Escoffery C; Schlueter D; Hannon PA
    Prev Sci; 2024 Apr; 25(Suppl 1):124-135. PubMed ID: 36952143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yield of Colonoscopy After a Positive Result From a Fecal Immunochemical Test OC-Light.
    Alsayid M; Singh MH; Issaka R; Laleau V; Day L; Lee J; Allison J; Somsouk M
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1593-1597.e1. PubMed ID: 29660528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Financial Incentives to Increase Colorectal Cancer Screening Uptake and Decrease Disparities: A Randomized Clinical Trial.
    Green BB; Anderson ML; Cook AJ; Chubak J; Fuller S; Kimbel KJ; Kullgren JT; Meenan RT; Vernon SW
    JAMA Netw Open; 2019 Jul; 2(7):e196570. PubMed ID: 31276178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic colonoscopy completion after abnormal fecal immunochemical testing and quality of tests used at 8 Federally Qualified Health Centers in Southern California: Opportunities for improving screening outcomes.
    Bharti B; May FFP; Nodora J; Martínez ME; Moyano K; Davis SL; Ramers CB; Garcia-Bigley F; O'Connell S; Ronan K; Barajas M; Gordon S; Diaz G; Ceja E; Powers M; Arredondo EM; Gupta S
    Cancer; 2019 Dec; 125(23):4203-4209. PubMed ID: 31479529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Precision Patient Navigation to Improve Rates of Follow-up Colonoscopy, An Individual Randomized Effectiveness Trial.
    Coronado GD; Rawlings AM; Petrik AF; Slaughter M; Johnson ES; Hannon PA; Cole A; Vu T; Mummadi RR
    Cancer Epidemiol Biomarkers Prev; 2021 Dec; 30(12):2327-2333. PubMed ID: 34583969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.